LAS VEGAS, Jan. 24, 2026 (GLOBE NEWSWIRE) -- University Medical Center Southern Nevada (UMC) has achieved Magnet® designation from the American Nurses Credentialing Center (ANCC), becoming the first ...

According to published research referenced by Direct Meds, NAD+ is a naturally occurring coenzyme involved in cellular energy production, DNA repair, and metabolic function. As NAD+ levels naturally ...

BASEL, Switzerland and LONDON and NEW YORK, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, ...

DURHAM, N.C. and NEW YORK, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Immunovant (Nasdaq: IMVT) today announced that it will report its financial results for the third quarter ended December 31, 2025, and ...

Corvus Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares, Generating Gross Proceeds of ...

The securities described above were offered by Erasca pursuant to a shelf registration statement on Form S-3, including a base prospectus, that was previously filed with the Securities and Exchange ...

Aja Health and Wellness Inc. ("Aja" or the "Company") (TSXV:Aja) announces that its wholly-owned subsidiary, Assured Diagnosis Inc. ("ADI"), has signed a broker agreement (the "Agreement") with ...

Tools for Humanity was co-founded by Sam Altman and Alex Blania and led the initial development of the World Project. The Orb is a device that allows an individual to verify that they are a unique ...

The behavioral aid category represents an emerging approach to addressing the ritualistic aspects of smoking and vaping habits. CAPNOS LEGURA represents one company's implementation within this space.

THE WOODLANDS, Texas, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will ring the Nasdaq Stock Market Closing Bell on Tuesday, January 27, ...

Ocugen intends to use the net proceeds from the offering for general corporate purposes, capital expenditures, working capital, and general and administrative expenses and anticipates that the net ...

XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a notification letter from The Listing Qualifications Department of The Nasdaq ...